CLRB icon

Cellectar Biosciences
CLRB

Overview Fund Activity

14 hedge funds and large institutions have $593K invested in Cellectar Biosciences in 2019 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 3 closing their positions.

Holders
14
Holders Change
-1
Holders Change %
-6.67%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Citadel Advisors
1
Citadel Advisors
Florida
$42K
2
KFS
2
Kelly Financial Services
Massachusetts
$63

Top Sellers

1
Morgan Stanley
1
Morgan Stanley
New York
$125K
2
UBS Group
2
UBS Group
Switzerland
$0
3
Renaissance Technologies
3
Renaissance Technologies
New York
$133K
Name Market Value Shares Shares
Change 		Shares
Change %
SFM
1
Sphera Funds Management
Israel
$206K 87,500 – –
Renaissance Technologies
2
Renaissance Technologies
New York
$133K 56,748 -300 -0.5%
Morgan Stanley
3
Morgan Stanley
New York
$125K 53,065 -13,005 -20%
Citadel Advisors
4
Citadel Advisors
Florida
$42K 17,760 +3,166 +22%
Vanguard Group
5
Vanguard Group
Pennsylvania
$39K 16,755 – –
Dimensional Fund Advisors
6
Dimensional Fund Advisors
Texas
$24K 10,300 – –
AIC
7
AWM Investment Company
New York
$11K 106,600 – –
US Bancorp
8
US Bancorp
Minnesota
$7K 2,859 – –
LTFS
9
Ladenburg Thalmann Financial Services
Florida
$5K 1,900 – –
SIM
10
Sonora Investment Management
Arizona
$1K 500 – –
KFS
11
Kelly Financial Services
Massachusetts
$63 27 +27 New
UBS Group
12
UBS Group
Switzerland
– – -5,696 Closed
WAM
13
Wealthspire Advisors (Maryland)
Maryland
$0 12 -82 -87%
IA
14
IFP Advisors
Florida
– – -30 Closed
Bank of America
15
Bank of America
North Carolina
– – -7 Closed
BlackRock
16
BlackRock
New York
$0 59 – –
CFGS
17
Concourse Financial Group Securities
Alabama
– – – –
AWM
18
AllSquare Wealth Management
New York
$0 188 +188 New